Inovio pharmaceuticals stock.
INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and prevent infectious diseases, cancer, and diseases associated with HPV, today announced that it has discontinued its internally funded efforts to develop INO-4800 as a COVID-19 heterologous booster vaccine. The …
Research & Development Center. 10480 Wateridge Circle San Diego, CA 92121 Phone: 858-597-60064 Mar 2020 ... Shares of Inovio Pharmaceuticals Inc., the genetic vaccine company, hit a four-year high Wednesday, rising as much as 16% to $9.40 a share ...Get a real-time Inovio Pharmaceuticals, Inc. (INO) stock price quote with breaking news, financials, statistics, charts and more.Inovio Pharmaceuticals 's revenue in 2023 is $854,026.On average, 3 Wall Street analysts forecast INO's revenue for 2023 to be $227,397,691, with the lowest INO revenue forecast at $191,090,497, and the highest INO revenue forecast at $272,986,424.See Inovio Pharmaceuticals, Inc. (INO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Aug 9, 2022 · As of June 30, 2022, INOVIO had 247.5 million shares of common stock outstanding and 267.8 million shares of common stock outstanding on a fully diluted basis, after giving effect to the exercise, vesting and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt.
Lead Case No. 2:20-cv-01962-GJP. NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER. DERIVATIVE ACTIONS. TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF INOVIO PHARMACEUTICALS, INC ...WebThe consensus among analysts is that Inovio Pharmaceuticals Inc (INO) is a Hold stock at the moment, with a recommendation rating of 3.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 3 have rated it as a Hold, with 0 advising it as a Buy. 0 have rated the stock as Underweight.
21 Des 2021 ... Inovio Pharmaceuticals (INO) ... The shares have a poor EPS Rating of 18. This reflects INO stock's continuing losses per share. On Dec. 21, ...Mar 1, 2023 · Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021 Inovio Pharmaceuticals reported quarterly losses of 15 cents per share which beat the analyst consensus estimate of a loss of 30 cents. The company also reported quarterly sales of $9.15 million ...Find the latest Inovio Pharmaceuticals, Inc. (INO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
11 Okt 2023 ... Inovio Pharmaceuticals (NASDAQ: INO) stock is up 50% on news from the FDA about the company's lead candidate. INO stock jumped on the news ...
Inovio Pharmaceuticals. Market Cap. $111M. Today's Change. (2.77%) $0.01. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ...
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading higher again on Wednesday after surging more than 40% on Tuesday after the FDA said it can use data from the completed Phase 1 ...17,042.88 +49.44(+0.29%) CRUDE OIL 76.00 -1.86(-2.39%) GOLD FUTURES 2,055.10 -12.00(-0.58%) DOW 35,763.06 +332.64(+0.94%) Bitcoin GBP 29,890.83 -117.13( …Discover Inovio Pharmaceuticals' earnings and revenue growth rates, forecasts, ... Inovio stock trades higher defying insider sale Jun 07. Consensus forecasts updated Jun 02. Consensus forecasts updated May 18. Forecast breakeven pushed back to …A community dedicated to Inovio Pharmaceuticals, the pioneers of DNA medicine. We welcome all who are seeking information and quality discussion regarding this incredible company. Created Aug 9, 2013. ... No unnecessary stock pumping or bashing. 4. Keep politics to a minimum.WebInovio Pharmaceuticals (NASDAQ:INO) stock rose ~7% on Thursday after the company reported results from a phase 3 trial and provided other clinical updates with its Q4 results.
Aug 9, 2022 · As of June 30, 2022, INOVIO had 247.5 million shares of common stock outstanding and 267.8 million shares of common stock outstanding on a fully diluted basis, after giving effect to the exercise, vesting and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt. 10 Okt 2023 ... Inovio Pharmaceuticals (INO) shares rise after FDA issued positive feedback on its plans to obtain marketing nod for lead asset against a ...Jun 27, 2022 · Inovio Pharmaceuticals (INO-5.75%) stock rose slightly on an otherwise gloomy day for the wider market. Investors were cheered by the appointment of a new chief medical officer at their company. The stock is down more than 43% year to date and more than 72% over the past year. ... Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript. 520%. Premium Investing Services.WebInovio Pharmaceuticals (INO) Q2 2023 Earnings Call Transcript finance.yahoo.com - August 9 at 9:04 PM: Inovio Pharmaceuticals cuts 30% of staff in third round of layoffs in 13 months bizjournals.com - August 1 at 7:38 PM: Inovio Pharmaceuticals (INO) Stock Up, Begins Recruitment for MERS Vaccine Trial thestreet.com - July 28 at 8:03 AM
Find the latest Inovio Pharmaceuticals, Inc. (INO.MX) stock quote, history, news and other vital information to help you with your stock trading and investing.WebA high-level overview of Inovio Pharmaceuticals, Inc. (INO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Safety and Immunological data from both cohorts of the recently completed Phase 1/2 trial will be presented on May 5 th. PLYMOUTH MEETING, Pa., April 27, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO ...Stock split history for Inovio Pharmaceuticals since 1998. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.Inovio Pharmaceuticals Insider Trading Activity 2023 (NASDAQ:INO) 34,095.86. 369.21. 5 Aerospace & Defense stocks under $5. New CBOE “special perk” helps traders target income every weekend (Ad) These 5 small-cap impact stocks are making social change. Pinterest surges 27%, best weekly gain in over a year. New …Find real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. ... Inovio Pharmaceuticals Inc (NASDAQ:INO) 0.4291. Delayed Data. As of Nov 17 ... The biotech stock, still reeling from a failed clinical trial, hit a 52-week low. ... Shares of Inovio Pharmaceuticals (INO 4.20%) were down more than 10% on Tuesday afternoon, ...Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Nasdaq 14,295.90 +0.39% +54.88 Russell 1,801.91 +0.042% +0.76 VIX 12.68 -0.079% -0.0100 Home INO • NASDAQ Inovio Pharmaceuticals Inc Follow Share $0.40 Nov 28, 11:47:07 AM GMT-5 · USD ·...
Research Inovio Pharmaceuticals' (Nasdaq:INO) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...
Discover Inovio Pharmaceuticals' earnings and revenue growth rates, forecasts, ... Inovio stock trades higher defying insider sale Jun 07. Consensus forecasts updated Jun 02. Consensus forecasts updated May 18. Forecast breakeven pushed back to …
The analysts covering Inovio Pharmaceuticals, Inc. ( NASDAQ:INO ) delivered a dose of ... seeing company management invest large sums of money in a stock can be just as useful as knowing whether ...WebFind real-time INO - Inovio Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.WebGet Inovio Pharmaceuticals Inc (INO.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.From 1998 through today, Inovio Pharmaceuticals' stock history has been largely a depressing one. A quick analysis of Inovio Pharmaceuticals ' ( INO 2.77%) stock performance history shows plenty ...Jun 23, 2023 · Lead Case No. 2:20-cv-01962-GJP. NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER. DERIVATIVE ACTIONS. TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF INOVIO PHARMACEUTICALS, INC ... Mar 1, 2023 · Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021 As of December 31, 2022, INOVIO had 253.1 million common shares outstanding and 271.0 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting, and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt.Nov 28, 2023 · 52-week High/Low: $2.07 / $0.32. 50/200 Day Moving Average: $0.407 / $0.664. This figure corresponds to the Average Price over the previous 50/200 days. For Inovio Pharmaceuticals stocks, the 50-day moving average is the support level today. For Inovio Pharmaceuticals stocks, the 200-day moving average is the resistance level today. Please complete this form relating to your transactions for Inovio Pharmaceuticals, Inc. (Nasdaq: INO) common stock between February 14, 2020 and March 9, ...ROBERT J. JUBA JR. “INOVIO’s team has extensive experience manufacturing DNA medicines and a proven track record of producing them at unprecedented speeds.”. “INOVIO’s CELLECTRA® intramuscular and intracellular smart devices have allowed us to deliver our optimized DNA plasmids directly into cells in the body to produce immune responses. Inovio Pharmaceuticals received the green light from regulators in the U.S. to run a late-stage study for its potential coronavirus vaccine. The company is planning to target countries where there ...
The stock is down more than 43% year to date and more than 72% over the past year. ... Inovio Pharmaceuticals (INO) Q4 2022 Earnings Call Transcript. 520%. Premium Investing Services.WebShares of Inovio Pharmaceuticals (INO 0.96%) ... There's also the worry the stock could be delisted from the Nasdaq Stock Market if it continues to trade below $1, which would make it more ...Investors, Inovio Get Final OK For $44M Deal In Stock Suit. A Pennsylvania federal judge on Wednesday approved a $44 million deal between biotechnology firm Inovio Pharmaceuticals Inc. and its ...In addition, Inovio Pharmaceuticals, Inc. has a VGM Score of D ... Inovio Pharma (INO) Stock Surges 19% This Month: Here's Why 10/19/23-8:53AM EST Zacks Inovio Pharmaceuticals ...Instagram:https://instagram. rvlvnadex forex tradingflorida double llcinteractive brokers penny stocks Inovio Pharmaceuticals Inc. analyst ratings, historical stock prices, ... Actuals & Estimates Inovio Pharmaceuticals Inc. Quarterly; Annual; Actual Analyst Range Consensus. 0.10 0.00-0.10-0.20 ... how much are half dollars worthdoes webull give free stocks INOVIO Pharmaceuticals Stock History June 1, 2020, started by offering investors new options as they wait for the July 10, 2020 expiration date. The INO stocks have been going up since March 2020. mfs utilities fund Nov 30, 2023 · Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA ... Shares of coronavirus vaccine developer Inovio Pharmaceuticals ( INO 1.39%) are down 11% to $8.50 apiece as of 10:30 a.m. EDT. The company reported second-quarter earnings after markets closed on ...Web